The changing profile of Ph-positive chronic myeloid leukemia at presentation: possible impact of earlier diagnosis on survival

Citation
F. Cervantes et al., The changing profile of Ph-positive chronic myeloid leukemia at presentation: possible impact of earlier diagnosis on survival, HAEMATOLOG, 84(4), 1999, pp. 324-327
Citations number
14
Categorie Soggetti
Cardiovascular & Hematology Research
Journal title
HAEMATOLOGICA
ISSN journal
03906078 → ACNP
Volume
84
Issue
4
Year of publication
1999
Pages
324 - 327
Database
ISI
SICI code
0390-6078(199904)84:4<324:TCPOPC>2.0.ZU;2-Q
Abstract
Background and Objective. Although there are indications that the profile o f chronic myeloid leukemia (CML) at presentation has changed in recent year s, information Is scarce. The objective of the present study was to ascerta in whether the initial features of CML have changed over time, as well as t he possible impact on survival. Design and Methods. The initial features of 167 patients diagnosed with chr onic phase ph-positive CML from 1972 to 1985 were compared with those of 17 4 such patients diagnosed at the same institution from 1985 to 1998. The su rvival of the two groups was also compared. Results. CML patients diagnosed since 1985 were significantly older at pres entation (mean age 47+17 vs 43+17 years, p = 0.04), were more often asympto matic (36% vs 19%, p = 0.0003), less often had constitutional symptoms (30% vs 45%, p = 0.004), less frequently had splenomegaly (59% vs 75%, p = 0.00 08) and hepatomegaly (35% vs 49%, p = 0.02), had less marked leukocytosis ( mean WBC count 139+/-124x10(9)/L vs 179+/-132x10(9)/L, p = 0.007), with 30% of them showing an initial WBC count below 50x10(9)/L (vs 19%, p = 0.02), and showed less marrow blast cell infiltration (p = 0.0003). No significant differences were observed in the distribution by Sokal's risk groups. Medi an survival of patients diagnosed since 1985 was 5.33 years (95% CI: 4.3-6. 36), vs 4.06 years (95% CI: 3.28-4.84) for patients diagnosed before (p = 0 .07). Finally, patients asymptomatic at diagnosis had a longer survival (me dian survival 5.7 years, 95% CI: 4.5-6.9, vs 4.1 years, 95% CI: 3.4-4.7, p = 0.03). Interpretation and Conclusions. A substantial proportion of CML patients ar e currently diagnosed early in the course of the disease. The effect of ear lier diagnosis on survival prolongation in such patients should be taken in to account. (C) 1999, Ferrata Storti Foundation.